(Press-News.org) Latino sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic, according to a new Rutgers study.
“Total HIV infection rates in the United States are stabilizing, which is good news,” said Gabriel Robles, an assistant professor at the Rutgers School of Social Work and coauthor of the paper published in the journal AIDS Education and Prevention. “What’s bad is that the trend for some subgroups, including some Latino/x sexual minority men, is going in the opposite direction. Our study offers a possible explanation.”
In a nationally representative study of 484 Latino sexual minority men and Latinx individuals, Rutgers researchers found a strong correlation between discrimination and delayed HIV testing. (The researchers adopted the term "Latino/x" to reflect participants who use the traditional term "Latino" and those who have adopted "Latinx"). Everyday discrimination – perceived bias based on race, ethnicity or sexual orientation during day-to-day life – may be one reason why this is occurring, researchers said.
To end the HIV epidemic in the U.S., a goal health authorities believe is possible by 2030, early detection is essential. But for some of the most vulnerable populations, testing frequency is falling far short of what’s needed. Delays in testing can increase the likelihood of transmission for those unaware of their HIV status.
Despite effective technologies to limit the virus’ spread, new HIV infections are increasing for some vulnerable populations while testing rates lag. Robles and Yong Gun Lee, a postdoctoral associate at the Rutgers School of Social Work and the study’s lead author, said discrimination might be a barrier to testing frequency.
To confirm their theory, the researchers analyzed data from a 2018-2019 national survey of sexual health and relationships among partnered Latino/x sexual minority men. That survey, which Robles conducted, asked respondents about experiences with discrimination and how often they tested for HIV.
Through multinomial regression analyses, the researchers found that discrimination and testing were linked.
“Compared with participants who were most recently tested within the past six months, those tested longer than 12 months were significantly more likely to have experienced discrimination based on both sexual orientation and race/ethnicity,” they wrote.
The researchers also found delayed testing was most common for Latino sexual minority men and Latinx individuals born outside the U.S., suggesting that migration status may be an additional barrier.
More research is needed to determine a definitive causal link between discrimination and HIV testing, said the authors. But previous work had linked poor health outcomes with discrimination in medical care settings. Particularly for migrants, access to care and services can be difficult because of language, culture and cost.
“We have the technology to stop this epidemic; it's things like this that are going to get in the way,” said Robles. “How can we bring the available medical technology to communities that need it? Only when we navigate psychosocial barriers will 2030 begin to look like a realistic goal.”
END
Ending the HIV epidemic may require addressing “everyday” discrimination
Medical technology alone will not stop transmission, Rutgers researchers say
2023-11-28
ELSE PRESS RELEASES FROM THIS DATE:
Anonymous $10 million gift to Henry Ford Health establishes lung cancer tissue repository, bolsters research
2023-11-28
As Lung Cancer Awareness Month comes to a close, Henry Ford Health is proud to announce it has received an anonymous gift of $10 million, which is poised to significantly advance lung cancer research at Henry Ford Cancer.
This transformative gift has enabled Henry Ford to establish a new lung cancer tissue biorepository, which is a facility that catalogs and stores biological samples for research. These samples – in this case, lung cancer tissue – are crucial for scientists who are studying ...
RCSI researchers develop material that reduces bacterial infection and speeds up bone healing
2023-11-28
28 November 2023: Researchers at RCSI University of Medicine and Health Sciences and Advanced Materials and Bioengineering Research Centre (AMBER) have developed a new surgical implant that has the potential to transform the treatment of complex bone infections. When implanted on an injured or infected bone, the material can not only speed up bone healing, it also reduces the risk of infections without the need for traditional antibiotics.
The newly published paper in the journal Advanced Materials, tackles the complex clinical problem of bone infection, ...
Contrast sensitivity of ON and OFF human retinal pathways in myopia
2023-11-28
Across the entire animal kingdom, visual images are processed by two major neuronal pathways that extract light and dark stimuli from visual scenes – ON (light on) and OFF (light off) pathways.
Light stimuli are brighter than their background like a white cloud in a gray sky whereas dark stimuli are darker than the background like a black bird in a blue sky. The two pathways can extract stimuli with different contrasts but some pathways are more sensitive than others. In carnivores and rodents, ON pathways are more sensitive ...
DFW air quality continues to miss EPA goals for safety
2023-11-28
Air quality in the Dallas-Fort Worth metropolitan area continues to miss safety levels set by the Environmental Protection Agency (EPA) and is unlikely to meet EPA goals anytime soon, according to new research from The University of Texas at Arlington.
Purnendu “Sandy” Dasgupta, professor of chemistry and biochemistry and the Hamish Small Chair of Ion Analysis at The University of Texas at Arlington, said the region’s low population density, lack of widespread public transportation and reliance on cars contribute to its poor air quality. Its ozone values have exceeded safety levels set by the EPA for the last 20 years.
“Compared ...
Many owners see little value in storing their firearms securely
2023-11-28
With more than 400 million privately owned firearms in circulation across the United States, gun violence prevention efforts have emphasized secure firearm storage as a method for preventing injury and death. But some owners may not see the value in doing so, according to Rutgers researchers.
Despite evidence that secure storage can effectively reduce the risk of suicide and unintentional shootings, many firearm owners typically keep at least one firearm stored loaded and unlocked, quickly accessible in case of home invasion. ...
PCORI approves $80.5 million for health research using novel approaches to tackle social and clinical care factors that contribute to maternal health inequities
2023-11-28
WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $80.5 million to support four new, ambitious patient-centered comparative clinical effectiveness research (CER) studies focused on both the health care and social factors that contribute to inequities in maternal morbidity and mortality. The trials are among 30 CER studies and related projects recently approved for PCORI funding.
Awarded through an innovative PCORI funding opportunity known as Partner for its focus on partnering research institutions and community organizations ...
Ohio State receives $14 million to study optimal aspirin therapy in pregnancy
2023-11-28
COLUMBUS, Ohio – A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.
During pregnancy, people are at risk of developing preeclampsia and gestational hypertension. Both disorders are characterized by high blood pressure and bring with them the potential for injury to the brain, lungs, kidneys and liver. These hypertensive disorders ...
University of Colorado Department of Medicine cardiologist lands $7 million funding award for nationwide study on improving heart-failure treatment
2023-11-28
Larry Allen, MD, chief of the Division of Cardiology at the University of Colorado School of Medicine, will receive a funding award for a nationwide study that he hopes will lead to more heart-failure patients getting the life-saving medications they need.
The $7 million in support, announced Nov. 28, is from the nonprofit Patient-Centered Outcomes Research Institute (PCORI), the leading U.S. funder of comparative clinical effectiveness research centered on patients.
Allen, a professor of cardiology in the CU Department of Medicine, says the funding award includes $2.5 million in direct support to CU, another $2.5 million to four other ...
PCORI approves $225 million in funding for dozens of health research studies and related projects
2023-11-28
WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical effectiveness research (CER) studies. By comparing various approaches to care, these studies will help fill evidence gaps related to maternal illness and death, adolescent mental health, delirium in older adults, cardiovascular disease and a range of other high-burden health conditions.
Four awards include support for large patient-centered CER studies in which community organizations and research institutions as coequal partners will tackle ...
Opioids vs. NSAIDS: which are safest and most effective for treating pain following surgery?
2023-11-28
LOS ANGELES (November 28, 2023)—Thousands of adolescents and young adults have outpatient surgery every day and are sent home with pain medication. Although the need for medication is clear, the best way to treat the pain is not. A new study led by investigators at the University of Michigan and Children’s Hospital Los Angeles will compare two treatment regimens—one that uses a regimen of non-opioid medication and another that adds a low-dose opioid—to determine the safest and most effective way to treat pain in adolescents and young adults recovering from common outpatient surgeries.
In the past, opioids ...
LAST 30 PRESS RELEASES:
Black youth, especially Black girls, use mental health services less than their White peers
Canada must protect youth from sports betting advertising
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
[Press-News.org] Ending the HIV epidemic may require addressing “everyday” discriminationMedical technology alone will not stop transmission, Rutgers researchers say